RxDoctor Payments Data

Aeri Kang

Internal Medicine · Brea, CANPI 1689660755

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 95.2% of the total across 67 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 24 manufacturers, the largest accounting for just 19.4% — the pattern of someone who eats at a lot of different presentations.

$1,232in general payments, 2019–2025

Across 67 payments — averaging $18.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AstraZeneca$239
  • Pfizer$162
  • Merck$127
  • Novo Nordisk$109
  • Lilly USA, LLC$92
  • Amgen$56
  • plus $447 from 18 others

What the payments were for

  • Consulting fees$202%
  • Food & beverage$1,17295%
  • Education$403%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$1,232 in reported general payments places this provider in the 75th percentile of 13,581 internal medicine providers in California.

See all internal medicine providers in California →

Other internal medicine in Brea

See the full list for California →

Where these figures come from

Is this you, or does something look wrong? →